SynthesisImmunity, inflammation and disease2024

Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID-19: A systematic review and meta-analysis.

Bahman Amani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.